Delivery Order SPE2DB24D1205-SPE2DB25FCWSL
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $9,286.57, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 21, 2025. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024, with a ceiling value of $4,433.73 and a completion date of December 17, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
The federal contract award summarized is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,238.03. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). This is a Firm Fixed Price Delivery Order contract, with no set-aside designation, that runs through July 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a generic prescription drug, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $4,218.99. The contract has an ultimate completion date of April 3, 2025 and was awarded on April 2, 2025. This contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award is for the delivery of Glimepiride 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $70,733.75. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that Amerisourcebergen holds with the DLA Troop Support Medical....
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,518.23 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,826.50 firm fixed-price delivery order contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GLIMEPIRIDE 1 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,138.32 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation that provides pharmaceutical products and services to U.S. government agencies. The contract is a firm fixed price delivery order with a potential value of $3,629.06 and a completion date of January 16, 2024. No set-aside was used for this award. Amerisourcebergen Drug Corp has...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $6,674.81 and a completion date of December 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The contract...